Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK interaction of tacrolimus with triazole antifungals in liver transplant recipients
ChiCTR2100053549Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Jan 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in mycoses (2 arms), sponsored by Huashan Hospital. Primary endpoint: Drug concentration. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
mycoses
Beyond the preview
Go deeper on ChiCTR2100053549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053549.